Mini-Focus Issue: Preventing Heart Failure HospitalizationJACC: Heart Failure Position PaperThe Hospital Readmissions Reduction Program: Nationwide Perspectives and Recommendations: A JACC: Heart Failure Position Paper
Central Illustration
Key Words
Abbreviations and Acronyms
Cited by (0)
Dr. Psotka has received consulting fees from Amgen, Cytokinetics, and Roivant. Dr Fonarow has received consulting fees from Abbott, Amgen, Bayer, Janssen, Medtronic, and Novartis. Dr. Allen has received research support from the Patient-Centered Outcomes Research Institute, the National Institutes of Health, and the American Heart Association; and consulting fees from Boston Scientific and Cytokinetics. Dr. Joynt Maddox has received research support from the National Heart, Lung, and Blood Institute (K23HL109177-03); and is a former employee of the U.S. Department of Health and Human Services, where she continues work on a limited basis as a contractor. Dr. Hernandez has received research support from AstraZeneca, Bayer, Luitpold, GlaxoSmithKline, Merck, Novartis, Portola Pharmaceuticals, and Verily; and honoraria from Amgen, Bayer, Boehringer Ingelheim, Boston Scientific, MyoKardia, Novartis, and Sanofi. Dr. O’Connor has received research funding from and has served as a consultant to ResMed, Merck, and Bristol-Myers Squibb; has served as a consultant to Stealth Peptides; and is a co-owner of BisCardia. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. John Teerlink, MD, served as Guest Editor for this paper.